CRB Inverbío

About The Fund

CRB Inverbio, also known as Cross Road Biotech, is a private venture capital management firm specializing in life sciences. They are primarily dedicated to investing in innovative early-stage startups within sectors such as biotech, med tech, digital health, and medical technologies. Founded in 2002 and based in Madrid, Spain, they leverage an extensive network and experience to provide advisory services and partner with emerging technology companies in their field of expertise, assisting in the development of business strategies and financing options. CRB Inverbio is committed to discovering new investment opportunities and maintaining a vibrant deal flow with high potential. The firm employs a hands-on investment approach and accesses a wide network of expertise, including a Scientific Advisory Board (SAB), venture partners, portfolio CEOs, Key Opinion Leaders (KOLs), and top-class local and global partners. They have established partnerships with leading biomedical research organizations and Life Science accelerators in Spain. With over €50 million under management, their portfolio encompasses some of the most promising healthcare technology-based companies in Spain. CRB Inverbio seeks to fill a market gap and contribute to the acceleration of industry and sector development. Registered at the Spanish Securities and Exchange Commission (CNMV), their investment approach is rooted in their origins in a Research Institution with links to the National Health System. They focus on disruptive solutions to unmet global clinical needs, with a clear regulatory pathway and strong intellectual property protection. Their targeted investments are in large markets, with the presence of potential customers and partners, and a solid path to potential high-return divestment opportunities.